EXHIBIT 4.9 REGISTRATION RIGHTS AGREEMENT AGREEMENT dated as of February 27, 1998 among PAREXEL International Corporation, a Massachusetts corporation (the "Company") and the stockholders listed on Schedule A hereto (individually, a "Stockholder," and...Registration Rights Agreement • May 29th, 1998 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
EMPLOYMENT AGREEMENTEmployment Agreement • May 15th, 1997 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
Between COVANCE INC., as Grantee and PAREXEL INTERNATIONAL CORPORATION, as IssuerStock Option Agreement • May 4th, 1999 • Parexel International Corp • Services-commercial physical & biological research • New York
AND JANET KAYShare Purchase Agreement • May 20th, 1997 • Parexel International Corp • Services-commercial physical & biological research
EXHIBIT 10.26 CHANGE OF CONTROL/SEVERANCE AGREEMENT This CHANGE OF CONTROL/SEVERANCE AGREEMENT, dated as of July 6, 2006 by and between PAREXEL International Corporation (together with all subsidiaries or affiliates hereinafter referred to as the...Severance Agreement • September 8th, 2006 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
EXHIBIT 10.2 CHANGE OF CONTROL AGREEMENT AGREEMENT, dated as of October 20, 1998, by and between PAREXEL International Corporation (the "Company") and William T. Sobo, Jr. (the "Executive").Parexel International Corp • November 13th, 1998 • Services-commercial physical & biological research
EXHIBIT 4.4 DATED 1998 SHARE ACQUISITION AGREEMENTAgreement • May 29th, 1998 • Parexel International Corp • Services-commercial physical & biological research
Exhibit 4.4 ASSET PURCHASE AGREEMENT dated as ofAsset Purchase Agreement • January 20th, 1998 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
c) up to the relevant maximum amount in euros specified in relation to that Account or group of Accounts together PURPOSE (a) Each Facility may only be used for the purposes of cash management in connection with the normal operation of the interest...Parexel International Corp • September 15th, 2003 • Services-commercial physical & biological research
EXECUTION VERSION (JP MORGAN LOGO) CREDIT AGREEMENT dated as of January 12, 2007Credit Agreement • January 19th, 2007 • Parexel International Corp • Services-commercial physical & biological research • New York
ARTICLE II RESTRICTED STOCK AWARDRestricted Stock Agreement • February 9th, 2006 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
1- 2 (8) months commencing on September 1, 2001 and expiring on April 30, 2009 (the "Interim Extended Term") unless sooner terminated in accordance with the provisions of the Lease, upon all the same terms and conditions contained in the Lease as...Parexel International Corp • September 25th, 2000 • Services-commercial physical & biological research
Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1 (f) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Entities (as such term is defined in the Schedule 13G)...Joint Filing Agreement • June 5th, 2002 • Parexel International Corp • Services-commercial physical & biological research
AMONGPurchase Agreement • October 13th, 2006 • Parexel International Corp • Services-commercial physical & biological research • California
AMONGPurchase Agreement • January 14th, 1997 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
ARTICLE I REFERENCE DATASubordination Agreement • September 25th, 2000 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1 (f) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Entities (as such term is defined in the Schedule 13G)...Joint Filing Agreement • January 17th, 2002 • Parexel International Corp • Services-commercial physical & biological research
RIGHTS AGREEMENT between PAREXEL INTERNATIONAL CORPORATION and EQUISERVE TRUST COMPANY, N.A., as Rights Agent Dated March 27, 2003Rights Agreement • March 31st, 2003 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
RIGHTS AGREEMENT, dated March 27, 2003 (the “Agreement”), between PAREXEL International Corporation, a Massachusetts corporation (the “Company”), and EquiServe Trust Company, N.A., a national banking association, as Rights Agent (the “Rights Agent”).
UNDERWRITING AGREEMENT ----------------------Underwriting Agreement • October 22nd, 1996 • Parexel International Corp • Services-commercial physical & biological research • New York
EXHIBIT 4.5 DATED 1998 SHARE ACQUISITION AGREEMENT A. JOSEPH EAGLE, GREGORY S. CASWILL AND OTHERS (1) PAREXEL INTERNATIONAL CORPORATION (2)Parexel International Corp • May 15th, 1998 • Services-commercial physical & biological research • Clarendon
SALE AND PURCHASE AGREEMENT - between - DR. DIETER RUSSMAN hereinafter referred to as the "Seller" - and - PAREXEL INTERNATIONAL CORPORATION hereinafter referred to as the "Purchaser"Sale and Purchase Agreement • May 29th, 1998 • Parexel International Corp • Services-commercial physical & biological research
AGREEMENT AND PLAN OF MERGER by and among PAREXEL INTERNATIONAL CORPORATION, WEST STREET PARENT, LLC and WEST STREET MERGER SUB, INC. JUNE 19, 2017Agreement and Plan of Merger • June 20th, 2017 • Parexel International Corp • Services-commercial physical & biological research • New York
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated June 19, 2017, is entered into by and among PAREXEL INTERNATIONAL CORPORATION, a Massachusetts corporation (the “Company”), WEST STREET PARENT, LLC, a Delaware limited liability company (“Parent”), and WEST STREET MERGER SUB, INC., a Massachusetts corporation and a wholly-owned subsidiary of Parent (“Merger Sub”).
EXHIBIT 10.6 AMENDMENT NO. 1 TO CHANGE OF CONTROL/SEVERANCE AGREEMENT This AMENDMENT NO. 1 TO CHANGE OF CONTROL/SEVERANCE AGREEMENT, dated as of February 7, 2006 by and between PAREXEL International Corporation (together with all subsidiaries or...Severance Agreement • February 9th, 2006 • Parexel International Corp • Services-commercial physical & biological research
PAREXEL INTERNATIONAL CORPORATION DIRECTOR INDEMNIFICATION AGREEMENTIndemnification Agreement • June 20th, 2017 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
This Indemnification Agreement (“Agreement”) is made as of June __, 2017 by and between PAREXEL International Corporation, a Massachusetts corporation (the “Company”), and (“Indemnitee”).
EXHIBIT 10.3 CHANGE OF CONTROL/SEVERANCE AGREEMENT This CHANGE OF CONTROL/SEVERANCE AGREEMENT, dated as of December 16, 2005 by and between PAREXEL International Corporation (together with all subsidiaries or affiliates hereinafter referred to as the...Severance Agreement • February 9th, 2006 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
AGREEMENTAn Agreement • September 15th, 2003 • Parexel International Corp • Services-commercial physical & biological research • England and Wales
EXHIBIT 10.4 CHANGE OF CONTROL AGREEMENT AGREEMENT, dated as of October 20, 1998, by and between PAREXEL International Corporation (the "Company") and Barry Philpott (the "Executive").Parexel International Corp • November 13th, 1998 • Services-commercial physical & biological research
Exhibit 4.2 AGREEMENT AND PLAN OF REORGANIZATION AND MERGERAgreement and Plan of Reorganization and Merger • January 20th, 1998 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
Exhibit 4.11 REGISTRATION RIGHTS AGREEMENT AGREEMENT dated as of February 27, 1998 among PAREXEL International Corporation, a Massachusetts corporation (the "Company") and Dr. Dieter Russman (the "Stockholder"). W I T N E S S E T H : WHEREAS, pursuant...Registration Rights Agreement • May 29th, 1998 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
THIRD AMENDED AND RESTATED CREDIT AGREEMENT Dated as of March 11, 2016 among PAREXEL INTERNATIONAL CORPORATION, and CERTAIN SUBSIDIARIES as Borrowers, THE SUBSIDIARY GUARANTORS PARTY HERETO, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line...Credit Agreement • March 17th, 2016 • Parexel International Corp • Services-commercial physical & biological research • New York
Any increase or decrease in the Applicable Rate resulting from a change in the Consolidated Net Leverage Ratio shall become effective as of the first Business Day immediately following the date a Compliance Certificate is delivered pursuant to Section 6.02(a); provided, however, that if a Compliance Certificate is not delivered when due in accordance with such Section, then, upon the request of the Required Lenders, Pricing Level VI shall apply as of the first Business Day after the date on which such Compliance Certificate was required to have been delivered and shall remain in effect until the date on which such Compliance Certificate is delivered. The Applicable Rate in effect from the Closing Date through the date on which a Compliance Certificate for the period ending September 30, 2016 is delivered (subject to the proviso in the immediately preceding sentence) shall be determined based upon Pricing Level II.
among COVANCE INC.,Agreement and Plan of Merger • May 4th, 1999 • Parexel International Corp • Services-commercial physical & biological research • New York
AMENDED AND RESTATED CREDIT AGREEMENT Dated as of March 22, 2013 among PAREXEL INTERNATIONAL CORPORATION, and CERTAIN SUBSIDIARIESas Borrowers, THE SUBSIDIARY GUARANTORS PARTY HERETO, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender...Credit Agreement • March 28th, 2013 • Parexel International Corp • Services-commercial physical & biological research • New York
This AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”) is entered into as of March 22, 2013, among PAREXEL INTERNATIONAL CORPORATION, a Massachusetts Corporation (the “Company”), certain Subsidiaries of the Company party hereto pursuant to Section 2.16 (each a “Designated Borrower” and, together with the Company, collectively, the “Borrowers” and, each, individually, a “Borrower”), certain Subsidiaries of the Company from time to time party hereto as Subsidiary Guarantors, each lender from time to time party hereto (collectively, the “Lenders” and, each, individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.
EXHIBIT 4.3 DATED 1998 SHARE ACQUISITION AGREEMENT TERRAFIRMA DESIGNS LIMITED (1) PAREXEL INTERNATIONAL CORPORATION (2)Share Acquisition Agreement • May 29th, 1998 • Parexel International Corp • Services-commercial physical & biological research
EXHIBIT 10.1 PAREXEL INTERNATIONAL CORPORATION NON-QUALIFIED STOCK OPTION AGREEMENT FOR EXECUTIVE OFFICERS PAREXEL International Corporation, a Massachusetts corporation (the "Company"), hereby grants as of the 8th day of September 2004 (the "Date of...Qualified Stock Option Agreement • November 8th, 2004 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
Exhibit 4.3 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 20th, 1998 • Parexel International Corp • Services-commercial physical & biological research • Massachusetts
